The rise of GLP-1s, which were initially approved for diabetes management and later for obesity treatment, underscores this ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

The drug has been approved to help treat type-2 diabetes, but a new study shows an increase in use in people with type-1 diabetes, and it may not be safe.

Discover 10 powerful lifestyle modifications that can prevent and potentially reverse type 2 diabetes naturally, from ...

It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...

Patients with diabetes who take semaglutide are at increased risk for NAION compared with patients who do not use GLP-1 RAs to control their blood sugar, a new study finds.

In patients with diabetes, semaglutide use was associated with an increased risk for nonarteritic anterior ischemic optic ...